OLIG2 (oligodendrocyte transcription factor 2)
| Gene | |
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
10215 |
|
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Oligodendrocyte transcription factor 2 |
|
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
OLIG2 |
|
Synonyms (NCBI Gene)
Gene synonyms aliases
|
BHLHB1, OLIGO2, PRKCBP2, RACK17, bHLHe19 |
|
Chromosome
Chromosome number
|
21 |
|
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
21q22.11 |
|
Summary
Summary of gene provided in NCBI Entrez Gene.
|
This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal transl |
|
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
|||||||
| Protein | |||||||||||
| UniProt ID | Q13516 | ||||||||||
| Protein name | Oligodendrocyte transcription factor 2 (Oligo2) (Class B basic helix-loop-helix protein 1) (bHLHb1) (Class E basic helix-loop-helix protein 19) (bHLHe19) (Protein kinase C-binding protein 2) (Protein kinase C-binding protein RACK17) | ||||||||||
| Protein function | Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain. Functions together with ZNF488 to promote oligodendrocyte differentiation. Cooperates with | ||||||||||
| Family and domains |
Pfam
|
||||||||||
| Tissue specificity | TISSUE SPECIFICITY: Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas highly variable. {ECO:0000269|PubMed:11498220, ECO:0000269|PubMed: | ||||||||||
| Sequence |
|
||||||||||
| Sequence length | 323 | ||||||||||
| Interactions | View interactions | ||||||||||